CFO
AMGN icon

Callan Family Office’s Amgen AMGN Stock Holding History

Callan Family Office’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7M Sell
33,352
-1,091
-3% -$389K 0.27% 74
2025
Q4 		$11.3M Buy
34,443
+4,786
+16% +$1.52M 0.24% 80
2025
Q3 		$8.37M Sell
29,657
-1,299
-4% -$377K 0.27% 78
2025
Q2 		$8.64M Buy
30,956
+16,247
+110% +$4.6M 0.27% 73
2025
Q1 		$4.58M Buy
14,709
+764
+5% +$226K 0.34% 64
2024
Q4 		$3.63M Buy
13,945
+11,801
+550% +$3.5M 0.23% 82
2024
Q3 		$691K Buy
2,144
+150
+8% +$49.1K 0.12% 85
2024
Q2 		$623K Buy
1,994
+825
+71% +$242K 0.12% 73
2024
Q1 		$332K Buy
+1,169
New +$342K 0.08% 74

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Callan Family Office's AMGN Position: Q1 2026 in Review

Callan Family Office reduced its Amgen (AMGN) stake by 3.2% in Q1 2026, selling an estimated $389K and leaving 33,352 shares worth $11.7M. The position accounts for 0.27% of the portfolio, ranked #74.

Callan Family Office first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Callan Family Office held 33,352 shares of Amgen worth $11.7M as of Q1 2026.
  • Callan Family Office sold 1,091 Amgen shares in Q1 2026, an estimated $389K.
  • Amgen made up 0.27% of Callan Family Office's portfolio in Q1 2026, its #74 holding.
  • Callan Family Office first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.